Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 188.88B P/E 33.02 EPS this Y 5.00% Ern Qtrly Grth -5.30%
Income 5.54B Forward P/E 23.51 EPS next Y 10.30% 50D Avg Chg 2.00%
Sales 40.73B PEG 2.79 EPS past 5Y 7.17% 200D Avg Chg 3.00%
Dividend 2.00% Price/Book 5.10 EPS next 5Y 8.15% 52W High Chg -6.00%
Recommedations 2.00 Quick Ratio - Shares Outstanding 1.74B 52W Low Chg 16.00%
Insider Own 0.52% ROA - Shares Float 1.73B Beta 0.72
Inst Own 76.95% ROE - Shares Shorted/Prior 10.75M/11.62M Price 108.62
Gross Margin 55.46% Profit Margin 13.65% Avg. Volume 4,711,008 Target Price 124.23
Oper. Margin 16.20% Earnings Date Oct 16 Volume 4,699,325 Change -1.73%
About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Abbott Laboratories News
07/26/24 Abbott Ordered to Pay $495 Million in Baby-Formula Verdict
07/26/24 Integer Holdings (ITGR) Q2 Earnings Top Estimates, Margins Up
07/26/24 ICON (ICLR) Q2 Earnings Surpass Estimates, Margins Expand
07/26/24 Better Buy: Abbott Laboratories vs. Intuitive Surgical
07/25/24 S&P 500’s Biggest Loser Has a Heart Valve Problem
07/25/24 The Zacks Analyst Blog Highlights SAP, Abbott Laboratories, Citigroup, Team and Vaso
07/25/24 3 High-Yielding Dividend Stocks That Can Help Bankroll Your Retirement Years
07/24/24 Top Analyst Reports for SAP, Abbott Laboratories & Citigroup
07/24/24 Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
07/24/24 Here’s Why Aristotle Atlantic’s Core Equity Composite Sold Abbott Laboratories (ABT)
07/23/24 Quest Diagnostics (DGX) Tops Q2 Earnings, Raises 2024 Outlook
07/19/24 Health Care Roundup: Market Talk
07/19/24 Q2 2024 Abbott Laboratories Earnings Call
07/18/24 Solar industry, AI chip stocks, Fed rate outlook: Market Domination
07/18/24 Abbott Makes A Bearish Move Despite 'Clean Print' That Includes A Guidance Boost
07/18/24 7 Safe Stocks to Buy for Volatility Insurance
07/18/24 Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript
07/18/24 Headwinds for airlines, pharmaceutical stocks slip: Morning Brief
07/18/24 Abbott Laboratories Posts Big Drop in COVID-19 Testing Revenue
07/18/24 Top Midday Stories: Taiwan Semiconductor, Novartis Shares Down Post-Earnings; Meta Weighs Bid for Ray-Ban Maker; Amazon Reports Record-Setting Prime Day
ABT Chatroom

User Image designhawg Posted - 59 minutes ago

$ABT sold a lot of $106. Will be interested in seeing how this shakes out on Monday. I'm gonna guess we'll see another 10% from here — and then I'll be right back in.

User Image ElFantasma661 Posted - 3 hours ago

$ABT decision got leaked about lawsuits? wtf is that move after hours.

User Image Pitbowl Posted - 5 hours ago

$ABT $MRMD $ABBV $AMGN $BAX https://www.bettyseddies.com/ https://marimedinc.com/brands

User Image Process Posted - 5 hours ago

$ABT Cramer said buy they taking Dexcom lunch (sugar free)

User Image Process Posted - 5 hours ago

$ABT Cramer James said to buy this yesterday! Hawk tuah on this

User Image Thelonius_Stonk Posted - 7 hours ago

$ABT made a higher high, now potentially putting in a higher low. big bullish above 114

User Image Boomrang Posted - 8 hours ago

$ABT here you go...... https://seekingalpha.com/news/4129212-abbott-labs-falls-after-jury-awards-plaintiff-95m-in-damages-in-baby-formula-case

User Image scorchedearth2023 Posted - 8 hours ago

$ABT Wait....what? Y'all invested in this without performing any due diligence? Here you go: "Abbott currently faces numerous lawsuits, including wrongful death, personal injury, and whistleblower actions, as well as consumer and investor class actions." You're welcome.

User Image Lexiteddy Posted - 8 hours ago

$ABT this is some bullshit. No news anywhere I can find

User Image Boomrang Posted - 8 hours ago

$ABT what happened? After hours is less than $100? Someone knows something......

User Image szama001 Posted - 8 hours ago

$ABT what happened?

User Image minter66 Posted - 13 hours ago

$ABT back to being Abbott stock

User Image Article_AI Posted - 13 hours ago

$ABT Should You Pick Abbott Stock At $105 After A Solid Q2? Abbott (NYSE: ABT) recently reported its Q2 results, with revenues and earnings exceeding our expectations. The company reported revenue of $10.4 billion and earnings of $1.14 on a per-share and adjusted basis, compared to our estimates of $10.3 billion and $1.10, respectively. https://www.stck.pro/news/ABT/86084960/

User Image Article_AI Posted - 15 hours ago

$ABT Better Buy: Abbott Laboratories vs. Intuitive Surgical Healthcare stocks are generally good bets, thanks to a rapidly growing population of older adults in the U.S. and other developed economies. Abbott Laboratories is growing sales at a high-single-digit annual percentage and offers a quarterly dividend. https://www.stck.pro/news/ABT/86072553/

User Image BossBishhh28 Posted - 16 hours ago

$ABT I saw DXCM and I saw ABT and these are no proportionate moves ha

User Image TpForMyBearHolio Posted - 17 hours ago

@gino2222 @DonCorleone77 doesn’t sensionics need to be surgically implanted? If so, not comparable to user applied sensor in terms of volumes. $ABT is the ultimate winner in this race.

User Image Oldpuck Posted - 20 hours ago

$ABT too bad ABT didn't post earnings this week instead of last market has been pretty favorable except DXCM

User Image profits101 Posted - 20 hours ago

$VKTX wasn't aware of this tidbit/tailwind (tracking $DXCM and $ABT): "The market for continuous glucose monitors is expected to expand rapidly, from $4.6 billion in 2023 to an estimated $7.51 billion in 2030, market researcher Grand View Research said in a recent report. Some of that will undoubtedly come amid growing rates of obesity. But experts say CGMs will also play a big part in monitoring glucose for people taking GLP-1 drugs for weight loss. Those include, currently, Novo Nordisk's (NVO) Wegovy and Eli Lilly's (LLY) Zepbound."

User Image lucy2134 Posted - 20 hours ago

$DXCM getting destroyed by $ABT !!!!

User Image divalu Posted - 22 hours ago

@BryGuy91 $ABBV is my second largest position. 🍎 $AAPL is my first! Been in $ABBV since $ABT, which I no longer hold, spun shares off to me.

User Image DKNGGUY Posted - 1 day ago

$ABBV $abt who else knew!

User Image ltdangle85 Posted - 1 day ago

$ABT wife works in Abbotts diabetes division. Soooo much money to be made here all ill say

User Image BlueStone19 Posted - 1 day ago

$ABT Very nice!

User Image Stocksrunner Posted - 2 days ago

$ABT Abbott Labs crosses above 200-day MA, bullish indicator. $106.64 now support. Look for follow-through and increased volume to confirm uptrend. https://stocksrunner.com/symbol/ABT

User Image Pearl_Power Posted - 2 days ago

$ABT looks good but weekly 250MA is key https://www.tradingview.com/x/ZuwA7Qcb/

User Image Trade_To_Profit Posted - 2 days ago

$ABT 110c 8/2

User Image Buckthetrend42 Posted - 2 days ago

$ABT $ABBV $CME Illinois stocks doing well

User Image iBoughtTheWrongTicker Posted - 2 days ago

$ABT I guess I was early

User Image iBoughtTheWrongTicker Posted - 2 days ago

$ABT strong ass recovery!!!

User Image AAAple Posted - 2 days ago

$ABT $107 in sight

Analyst Ratings
Evercore ISI Group Outperform Jul 2, 24
RBC Capital Outperform Jun 4, 24
Goldman Sachs Buy May 30, 24
Citigroup Buy May 22, 24
Barclays Overweight Apr 22, 24
RBC Capital Outperform Apr 18, 24
Evercore ISI Group Outperform Apr 4, 24
Citigroup Buy Apr 3, 24
RBC Capital Outperform Feb 14, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Jan 29 Sell 112.5 42,500 4,781,250 65,027 01/31/24
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Jan 29 Option 52.17 42,500 2,217,225 82,527 01/31/24
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Dec 14 Sell 108 15,000 1,620,000 65,027 12/18/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Dec 14 Option 44.4 15,000 666,000 80,027 12/18/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 08 Sell 105.95 10,400 1,101,880 65,027 08/10/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 08 Option 38.4 5,000 192,000 75,427 08/10/23
STARKS DANIEL J Director Director Jul 27 Sell 113.72 50,000 5,686,000 6,775,316 07/28/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT May 02 Sell 110.56 8,226 909,467 70,427 05/03/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT May 02 Option 47 8,226 386,622 78,653 05/03/23
STARKS DANIEL J Director Director Apr 28 Sell 111.36 50,000 5,568,000 6,825,316 05/02/23
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,032 103,922 52,203 03/02/23
Morrone Louis H. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,092 109,964 53,656 03/02/23
Moreland Mary K EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.77 717 72,252 87,224 03/02/23
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 1,339 134,837 62,323 03/02/23
Ginascol John F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 943 94,960 118,380 03/02/23
Funck, Jr. Robert E. EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 1,264 127,285 218,237 03/02/23
Earnhardt Lisa D EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 943 94,960 75,437 03/02/23
DALE MICHAEL D SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,209 121,746 45,133 03/02/23
ALLEN HUBERT L EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 1,069 107,648 175,959 03/02/23
Ahlberg Gregory A SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,317 132,622 38,420 03/02/23
Karam Sammy SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Dec 29 Sell 108.75 4,200 456,750 26,462 01/03/23
Ginascol John F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Dec 13 Sell 112.32 11,000 1,235,520 111,912 12/15/22
STARKS DANIEL J Director Director Oct 27 Sell 97.72 50,000 4,886,000 6,873,500 10/31/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Sep 08 Option 44.4 23,008 1,021,555 76,253 09/09/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Sep 08 Sell 107 23,008 2,461,856 53,245 09/09/22
Ford Robert B CHAIRMAN AND CEO CHAIRMAN AND CEO Aug 25 Option 40.13 102,425 4,110,315 244,496 08/26/22
Ford Robert B CHAIRMAN AND CEO CHAIRMAN AND CEO Aug 25 Sell 105.1 102,425 10,764,868 142,071 08/26/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 25 Option 44.4 23,008 1,021,555 80,143 08/26/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 25 Sell 105.12 26,898 2,827,518 53,245 08/26/22
STARKS DANIEL J Director Director Jul 26 Sell 109.19 50,000 5,459,500 6,923,500 07/28/22
Mateus Fernando SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Jul 26 Sell 109.0529 2,457 267,943 14,503 07/27/22
Tyler Julie L. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Jul 25 Sell 109.09 253 27,600 33,868 07/27/22
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT May 04 Option 44.4 24,000 1,065,600 71,854 05/05/22
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT May 04 Sell 113 24,000 2,712,000 47,854 05/05/22
STARKS DANIEL J Director Director May 03 Sell 113.55 50,000 5,677,500 6,973,500 05/05/22
DALE MICHAEL D SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Mar 08 Sell 117.0003 4,000 468,001 41,780 03/10/22
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.1 964 113,848 49,223 03/02/22
Watkin Jared SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.1 1,038 122,588 66,545 03/02/22
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.13 456 53,867 62,172 03/02/22
Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.17 1,550 183,164 112,248 03/02/22
Morrone Louis H. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.16 656 77,513 47,278 03/02/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.16 779 92,047 60,873 03/02/22
Ginascol John F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.16 365 43,128 124,680 03/02/22
Earnhardt Lisa D EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.15 943 111,415 90,630 03/02/22
DALE MICHAEL D SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.15 1,053 124,412 45,780 03/02/22
Calamari Christopher J. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.15 706 83,414 25,658 03/02/22
ALLEN HUBERT L EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.17 1,450 171,346 167,095 03/02/22
Ahlberg Gregory A SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.15 1,099 129,847 33,274 03/02/22
McKinstry Nancy Director Director Feb 24 Option 29.84 6,280 187,395 33,419 02/25/22
McKinstry Nancy Director Director Feb 24 Sell 116.43 1,614 187,918 31,805 02/25/22